Status:
TERMINATED
Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
ESRD
Extracellular Fluid Alteration
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study is an open label randomized clinical trial that comparing intradialytic blood pressure slope-based ultrafiltration prescriptions to standard care in the chronic fluid management of maintena...
Eligibility Criteria
Inclusion
- Age greater than 18 years
- End Stage Renal Disease on Maintenance Hemodialysis
- Hypertension defined as systolic blood pressure \> 140 mmHg pre-dialysis or \>130 mmHg post dialysis
Exclusion
- Hemodialysis Vintage \< 1 month
- Pregnancy
- Nadir Systolic Blood Pressure \< 95 mmHg
- Pre or Post dialysis systolic blood pressure \> 180 mmHg
- Decrease in systolic blood pressure \>60 mmHg from pre to post dialysis
- Ultrafiltration rate \>13 mL/kg/hr
- Peridialytic Midodrine Use
- Intradialytic Clonidine use
- Documented Antihypertensive Medication Non-adherence
- Bioimpedance will not be peformed on patients with
- amputated arms or legs
- cardiac defibrillator or pacemaker
- presence of metal prostheses
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT03303391
Start Date
November 1 2017
End Date
January 1 2020
Last Update
August 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Davita Dialysis
Dallas, Texas, United States, 75390